SCHEMBL30054700

SCHEMBL30054700

N#Cc1cc(F)cc2c1NCCC2F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30054577 0.83 EPAS1 (0.36) —
SCHEMBL26503987 0.83 PDE9A (0.33) —
SCHEMBL30053857 0.83 — —
SCHEMBL30054478 0.80 CYP11B1 (0.33) —
SCHEMBL30054188 0.75 — —
SCHEMBL23832873 0.73 — —
SCHEMBL30055213 0.73 — —
SCHEMBL30054476 0.72 EPAS1 (0.33) —
SCHEMBL10300799 0.71 PARP1 (0.35) —
SCHEMBL28879593 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4121409-A1 TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA Arcus Biosciences, Inc. (US) 2023-01-25 — — EP disclosed
CN-115298165-A Tetralin and tetrahydroquinoline compounds as HIF-2 alpha inhibitors 艾库斯生物科学有限公司 2022-11-04 — — CN disclosed
Send feedback